Author | Komal L. Jhaveri, MD, FACP | OncLive

Author | Komal L. Jhaveri, MD, FACP

Articles

Dr. Jhaveri Discusses a Basket Trial of Taselisib in Solid Tumors

August 29, 2018

Video

Komal L. Jhaveri, MD, FACP, medical oncologist, Memorial Sloan Kettering Cancer Center, discusses a basket trial of taselisib in patients with PIK3CA-mutated locally advanced or metastatic solid tumors.

Dr. Jhaveri on Results of Taselisib in PIK3CA-Mutated Metastatic Solid Tumors

April 19, 2018

Video

Komal L. Jhaveri, MD, FACP, medical oncologist, Memorial Sloan Kettering Cancer Center, discusses the results of a basket study of taselisib in patients with PIK3CA-mutated solid tumors.

A New World of Targeted Therapies for HER2-Positive Breast Cancer Takes Shape

December 17, 2014

Article

When added to standard chemotherapy, trastuzumab not only dramatically improved disease-free survival rates for patients with metastatic disease, but also resulted in a clear survival advantage unprecedented for most treatments of metastatic breast cancer.

x